Nebraska Medicine taps technology for use in clinics.
Ophthalmology Times: July 2024
iStent implantations increased sharply, whereas trabeculectomies saw a decline.
Therapeutics can prevent vision loss and neurodegeneration in patients.
Early diagnosis of NMOSD is key to preventing disability, improving survival.
TFI employs spectral interference technology to image and map the corneal surface.
Researchers train deep learning model on OCT scans to ID patients eligible for GA trials.
Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
The key to successful management of oGVHD is early diagnosis
NVK002 atropine 0.01% (Vyluma Inc.) “meaningfully slowed” myopia progression in myopic pediatric patients over a 36-month period.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
2
TECNIS PureSee IOL launches in US following FDA approval for cataract surgery
3
Dompé initiates phase 3 Orunea trial of cenegermin-bkbj in PCED
4
Heidelberg Engineering announces FDA clearance for new SPECTRALIS software release
5